PGI24 Cost-Effectiveness Analysis of 48-Week Peginterferon Alpha-2a Under RGT Strategy Versus 3 Years Entecavir for the Treatment of HBeAg-Positive Chronic Hepatitis B in China

✍ Scribed by W. Zhang; H. Zhuang; H. Ren; X. Dou; W. Chen

• Book ID: 119312727
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 61 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.08.773